Drug General Information |
Drug ID |
D05REH
|
Former ID |
DIB011182
|
Drug Name |
Flosulide
|
Synonyms |
CGP-28238; CGP-28328; CGS-28238; SH-459; ZK-38997
|
Drug Type |
Small molecular drug
|
Indication |
Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89]
|
Terminated |
[1]
|
Company |
Novartis AG
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C16H13F2NO4S
|
Canonical SMILES |
S(=O)(=O)(Nc1c(cc2c(c1)CCC2=O)Oc1c(cc(cc1)F)F)C
|
CAS Number |
CAS 80937-31-1
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Prostaglandin G/H synthase 2 |
Target Info |
Modulator |
[2]
|
BioCyc Pathway
|
Aspirin-triggered lipoxin biosynthesis
|
Aspirin triggered resolvin D biosynthesis
|
C20 prostanoid biosynthesis
|
Aspirin triggered resolvin E biosynthesis
|
KEGG Pathway
|
Arachidonic acid metabolism
|
Metabolic pathways
|
NF-kappa B signaling pathway
|
VEGF signaling pathway
|
TNF signaling pathway
|
Retrograde endocannabinoid signaling
|
Serotonergic synapse
|
Ovarian steroidogenesis
|
Oxytocin signaling pathway
|
Regulation of lipolysis in adipocytes
|
Leishmaniasis
|
Pathways in cancer
|
Chemical carcinogenesis
|
MicroRNAs in cancer
|
Small cell lung cancer
|
NetPath Pathway
|
IL1 Signaling Pathway
|
TSH Signaling Pathway
|
IL4 Signaling Pathway
|
TGF_beta_Receptor Signaling Pathway
|
IL5 Signaling Pathway
|
PANTHER Pathway
|
Endothelin signaling pathway
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
Toll receptor signaling pathway
|
CCKR signaling map ST
|
Pathway Interaction Database
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
S1P1 pathway
|
C-MYB transcription factor network
|
Signaling mediated by p38-alpha and p38-beta
|
Calcium signaling in the CD4+ TCR pathway
|
PathWhiz Pathway
|
Arachidonic Acid Metabolism
|
WikiPathways
|
Prostaglandin Synthesis and Regulation
|
Arachidonic acid metabolism
|
Aryl Hydrocarbon Receptor
|
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
|
Spinal Cord Injury
|
Integrated Pancreatic Cancer Pathway
|
Eicosanoid Synthesis
|
Selenium Micronutrient Network
|
References |
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000942) |
---|
REF 2 | Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int. 1999 Nov;56(5):1770-8. |